Hege Elisabeth Sollie-Zetlmayer
Director · PTC THERAPEUTICS, INC.
Individual
- 2026
- Jul 31, 2026
- 1
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Hege Elisabeth Sollie-Zetlmayer files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Neil Gregory Almstead - $16.35M in PTCT purchases and sales in the last 12 months
- Michael Schmertzler - $6.47M in PTCT purchases and sales in the last 12 months
- Mark Elliott Boulding - $4.08M in PTCT purchases and sales in the last 12 months
- Matthew B. Klein - $3.60M in PTCT purchases and sales in the last 12 months
- Eric Pauwels - $2.61M in PTCT purchases and sales in the last 12 months
- Emma Reeve - $2.49M in PTCT purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Hege Elisabeth Sollie-Zetlmayer?
Hege Elisabeth Sollie-Zetlmayer is a corporate insider, tracked as Director of PTC THERAPEUTICS, INC. (PTCT). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Hege Elisabeth Sollie-Zetlmayer submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
